Pharmaceuticals, Biotechnology and Life Sciences
GlaxoSmithKline has appointed Luke Miels President, Global Pharmaceuticals, GSK. He will be responsible for a portfolio of medicines and vaccines with annual sales of more than £15 billion and operations in over 100 markets.
French drugmaker Adocia, encouraged by the outcome of its project BC Lispro, has set its goal on partnering up with companies that have “more mature projects”, such is Eli Lilly with whom Adocia worked on BC Lispro.
Horizon Pharmaceuticals has warned by the Food and Drug Administration (FDA) to better respond on resolving certain issues it had in its drug manufacturing facilities, that the FDA pointed out after an inspection in 2015.
Eli Lilly has bought a biotech company focusing on pain management, CoLucid Pharmaceuticals for approximately $960 million, ($46.50 per share)…
Moberg Pharma’s New Skin Spray SKU will be sold in 3,900 Walmart stores and in over 1,500 Walgreens stores.
Hikma Pharmaceuticals’s US subsidiary Roxane Laboratories has received an approval from the US Food and Drug Administration for its Sodium…
Horizon Blue Cross Blue Shield (Horizon BCBS) of New Jersey has issued a positive medical policy for the MDxHealth’s ConfirmMDx for Prostate Cancer test.
OptiBiotix Health, a life sciences business developing compounds to tackle obesity, highcholesterol, diabetes and skin care, has appointed Christina Wood as Sales and Marketing Director.
Galapagos has appointed Dr. Walid Abi-Saab as a Chief Medical Officer (CMO), who came from Shire Pharmaceuticals, beginning on March 1, 2017.
Zealand Pharma has announced a $10 million milestone payment following Sanofi’s announcement of European Commission marketing authorization in Europe for…